nodes	percent_of_prediction	percent_of_DWPC	metapath
Chlormerodrin—SLC12A1—Cation-coupled Chloride cotransporters—SLC12A2—skin cancer	0.087	0.784	CbGpPWpGaD
Chlormerodrin—SLC12A1—appendage—skin cancer	0.0742	0.343	CbGeAlD
Chlormerodrin—Gastrointestinal ulcer haemorrhage—Fluorouracil—skin cancer	0.0693	0.103	CcSEcCtD
Chlormerodrin—ALDH5A1—nipple—skin cancer	0.0401	0.185	CbGeAlD
Chlormerodrin—Hyponatraemia—Vismodegib—skin cancer	0.0333	0.0494	CcSEcCtD
Chlormerodrin—Tenderness—Imiquimod—skin cancer	0.0276	0.041	CcSEcCtD
Chlormerodrin—Ulcer—Imiquimod—skin cancer	0.0254	0.0378	CcSEcCtD
Chlormerodrin—ALDH5A1—lymphoid tissue—skin cancer	0.0208	0.0961	CbGeAlD
Chlormerodrin—Necrosis—Dactinomycin—skin cancer	0.0203	0.0302	CcSEcCtD
Chlormerodrin—SLC12A1—epithelium—skin cancer	0.0201	0.0931	CbGeAlD
Chlormerodrin—ALDH5A1—female reproductive system—skin cancer	0.02	0.0927	CbGeAlD
Chlormerodrin—Extravasation—Bleomycin—skin cancer	0.0196	0.0291	CcSEcCtD
Chlormerodrin—Tenderness—Bleomycin—skin cancer	0.0196	0.0291	CcSEcCtD
Chlormerodrin—Extravasation—Dactinomycin—skin cancer	0.0183	0.0271	CcSEcCtD
Chlormerodrin—Ulcer—Bleomycin—skin cancer	0.0181	0.0268	CcSEcCtD
Chlormerodrin—Necrosis—Fluorouracil—skin cancer	0.0169	0.0251	CcSEcCtD
Chlormerodrin—Ulcer—Dactinomycin—skin cancer	0.0168	0.025	CcSEcCtD
Chlormerodrin—ALDH5A1—head—skin cancer	0.0167	0.0775	CbGeAlD
Chlormerodrin—Tenderness—Fluorouracil—skin cancer	0.0152	0.0226	CcSEcCtD
Chlormerodrin—Extravasation—Fluorouracil—skin cancer	0.0152	0.0226	CcSEcCtD
Chlormerodrin—Phlebitis—Bleomycin—skin cancer	0.0144	0.0214	CcSEcCtD
Chlormerodrin—Ulcer—Fluorouracil—skin cancer	0.014	0.0209	CcSEcCtD
Chlormerodrin—Phlebitis—Dactinomycin—skin cancer	0.0134	0.02	CcSEcCtD
Chlormerodrin—SLC12A1—head—skin cancer	0.0125	0.0577	CbGeAlD
Chlormerodrin—Necrosis—Docetaxel—skin cancer	0.0122	0.0181	CcSEcCtD
Chlormerodrin—ALDH5A1—lymph node—skin cancer	0.0117	0.0542	CbGeAlD
Chlormerodrin—Diarrhoea—Vismodegib—skin cancer	0.0111	0.0166	CcSEcCtD
Chlormerodrin—Extravasation—Docetaxel—skin cancer	0.011	0.0163	CcSEcCtD
Chlormerodrin—SLC12A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC12A2—skin cancer	0.0108	0.0973	CbGpPWpGaD
Chlormerodrin—Vomiting—Vismodegib—skin cancer	0.0104	0.0154	CcSEcCtD
Chlormerodrin—Rash—Vismodegib—skin cancer	0.0103	0.0153	CcSEcCtD
Chlormerodrin—Dermatitis—Vismodegib—skin cancer	0.0103	0.0152	CcSEcCtD
Chlormerodrin—Infection—Vemurafenib—skin cancer	0.00999	0.0149	CcSEcCtD
Chlormerodrin—Nausea—Vismodegib—skin cancer	0.00967	0.0144	CcSEcCtD
Chlormerodrin—Gastrointestinal haemorrhage—Fluorouracil—skin cancer	0.00964	0.0143	CcSEcCtD
Chlormerodrin—Infection—Imiquimod—skin cancer	0.00852	0.0127	CcSEcCtD
Chlormerodrin—Phlebitis—Docetaxel—skin cancer	0.00808	0.012	CcSEcCtD
Chlormerodrin—Body temperature increased—Vemurafenib—skin cancer	0.00795	0.0118	CcSEcCtD
Chlormerodrin—Hyponatraemia—Docetaxel—skin cancer	0.00698	0.0104	CcSEcCtD
Chlormerodrin—Gastrointestinal haemorrhage—Docetaxel—skin cancer	0.00696	0.0103	CcSEcCtD
Chlormerodrin—Diarrhoea—Vemurafenib—skin cancer	0.00688	0.0102	CcSEcCtD
Chlormerodrin—Body temperature increased—Imiquimod—skin cancer	0.00678	0.0101	CcSEcCtD
Chlormerodrin—Vomiting—Vemurafenib—skin cancer	0.0064	0.00951	CcSEcCtD
Chlormerodrin—Rash—Vemurafenib—skin cancer	0.00634	0.00943	CcSEcCtD
Chlormerodrin—Dermatitis—Vemurafenib—skin cancer	0.00634	0.00942	CcSEcCtD
Chlormerodrin—Infection—Bleomycin—skin cancer	0.00606	0.009	CcSEcCtD
Chlormerodrin—Nausea—Vemurafenib—skin cancer	0.00598	0.00888	CcSEcCtD
Chlormerodrin—Diarrhoea—Imiquimod—skin cancer	0.00587	0.00872	CcSEcCtD
Chlormerodrin—Infection—Dactinomycin—skin cancer	0.00565	0.00839	CcSEcCtD
Chlormerodrin—Vomiting—Imiquimod—skin cancer	0.00546	0.00811	CcSEcCtD
Chlormerodrin—Rash—Imiquimod—skin cancer	0.00541	0.00804	CcSEcCtD
Chlormerodrin—Dermatitis—Imiquimod—skin cancer	0.0054	0.00803	CcSEcCtD
Chlormerodrin—Infection—Temozolomide—skin cancer	0.00511	0.00759	CcSEcCtD
Chlormerodrin—Nausea—Imiquimod—skin cancer	0.0051	0.00757	CcSEcCtD
Chlormerodrin—SLC12A1—SLC-mediated transmembrane transport—SLC12A2—skin cancer	0.00483	0.0435	CbGpPWpGaD
Chlormerodrin—Body temperature increased—Bleomycin—skin cancer	0.00482	0.00716	CcSEcCtD
Chlormerodrin—Infection—Fluorouracil—skin cancer	0.00471	0.00699	CcSEcCtD
Chlormerodrin—Body temperature increased—Dactinomycin—skin cancer	0.00449	0.00668	CcSEcCtD
Chlormerodrin—Body temperature increased—Temozolomide—skin cancer	0.00406	0.00604	CcSEcCtD
Chlormerodrin—Diarrhoea—Dactinomycin—skin cancer	0.00389	0.00578	CcSEcCtD
Chlormerodrin—Vomiting—Bleomycin—skin cancer	0.00388	0.00576	CcSEcCtD
Chlormerodrin—Rash—Bleomycin—skin cancer	0.00384	0.00571	CcSEcCtD
Chlormerodrin—Dermatitis—Bleomycin—skin cancer	0.00384	0.00571	CcSEcCtD
Chlormerodrin—Body temperature increased—Fluorouracil—skin cancer	0.00374	0.00557	CcSEcCtD
Chlormerodrin—Nausea—Bleomycin—skin cancer	0.00362	0.00538	CcSEcCtD
Chlormerodrin—Vomiting—Dactinomycin—skin cancer	0.00361	0.00537	CcSEcCtD
Chlormerodrin—Rash—Dactinomycin—skin cancer	0.00358	0.00533	CcSEcCtD
Chlormerodrin—Diarrhoea—Temozolomide—skin cancer	0.00352	0.00523	CcSEcCtD
Chlormerodrin—Infection—Docetaxel—skin cancer	0.0034	0.00505	CcSEcCtD
Chlormerodrin—Nausea—Dactinomycin—skin cancer	0.00338	0.00502	CcSEcCtD
Chlormerodrin—Vomiting—Temozolomide—skin cancer	0.00327	0.00486	CcSEcCtD
Chlormerodrin—Rash—Temozolomide—skin cancer	0.00324	0.00482	CcSEcCtD
Chlormerodrin—Diarrhoea—Fluorouracil—skin cancer	0.00324	0.00482	CcSEcCtD
Chlormerodrin—Dermatitis—Temozolomide—skin cancer	0.00324	0.00481	CcSEcCtD
Chlormerodrin—Nausea—Temozolomide—skin cancer	0.00305	0.00454	CcSEcCtD
Chlormerodrin—Vomiting—Fluorouracil—skin cancer	0.00301	0.00448	CcSEcCtD
Chlormerodrin—Rash—Fluorouracil—skin cancer	0.00299	0.00444	CcSEcCtD
Chlormerodrin—Dermatitis—Fluorouracil—skin cancer	0.00298	0.00443	CcSEcCtD
Chlormerodrin—Nausea—Fluorouracil—skin cancer	0.00281	0.00418	CcSEcCtD
Chlormerodrin—Body temperature increased—Docetaxel—skin cancer	0.0027	0.00402	CcSEcCtD
Chlormerodrin—SLC12A1—Transmembrane transport of small molecules—SLC12A2—skin cancer	0.00245	0.0221	CbGpPWpGaD
Chlormerodrin—Diarrhoea—Docetaxel—skin cancer	0.00234	0.00348	CcSEcCtD
Chlormerodrin—ALDH5A1—Transmission across Chemical Synapses—BRAF—skin cancer	0.00228	0.0206	CbGpPWpGaD
Chlormerodrin—Vomiting—Docetaxel—skin cancer	0.00217	0.00323	CcSEcCtD
Chlormerodrin—Rash—Docetaxel—skin cancer	0.00216	0.0032	CcSEcCtD
Chlormerodrin—Dermatitis—Docetaxel—skin cancer	0.00215	0.0032	CcSEcCtD
Chlormerodrin—Nausea—Docetaxel—skin cancer	0.00203	0.00302	CcSEcCtD
Chlormerodrin—ALDH5A1—Neuronal System—BRAF—skin cancer	0.00175	0.0158	CbGpPWpGaD
Chlormerodrin—ALDH5A1—Transmission across Chemical Synapses—HRAS—skin cancer	0.00105	0.00946	CbGpPWpGaD
Chlormerodrin—ALDH5A1—Neuronal System—HRAS—skin cancer	0.000804	0.00725	CbGpPWpGaD
